Inventor · disambiguated record
Elke Jager
Also filed as: JAEGER ELKE · JAGER ELKE · JäGER ELKE · SCANLAN LEGAL REPRESENTATIVE C
28 granted patents·5 pending applications·281 citations·filing 1996–2021
96Inventor score
Files withLUDWIG INST CANCER RES18SLOAN KETTERING INST CANCER4CORNELL RES FOUNDATION INC3KNUTH ALEXANDER2ESSLINGER CHRISTOPH1
Top patents by PatentIndex Score
33 records- 0187US6525177B2Truncated forms of NY-ESO-1 proteinCORNELL RES FOUNDATION INC·Filed 2000·Granted Feb 25, 2003·17 cites·5 claims
- 0284US6911529B1Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereofSLOAN KETTERING INST CANCER·Filed 2000·Granted Jun 28, 2005·13 cites·13 claims
- 0384US6448073B1Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereofLUDWIG INST CANCER RES·Filed 2000·Granted Sep 10, 2002·11 cites·25 claims
- 0480US6096313ACompositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvantLUDWIG INST CANCER RES·Filed 1996·Granted Aug 1, 2000·56 cites·18 claims
- 0578US6274145B1Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereofLUDWIG INST CANCER RES·Filed 1997·Granted Aug 14, 2001·35 cites·8 claims
- 0676US6252052B1Antibodies which bind to NY-ESO-1 cancer associated proteins, and hybridomas which produce these antibodiesCORNELL RES FOUNDATION INC·Filed 1998·Granted Jun 26, 2001·34 cites·4 claims
- 0773US7291335B2Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereofLUDWIG INST CANCER RES·Filed 2001·Granted Nov 6, 2007·2 cites·7 claims
- 0873US6774226B1Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereofLUDWIG INST CANCER RES·Filed 1999·Granted Aug 10, 2004·15 cites·18 claims
- 0972US7115729B2Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53SLOAN KETTERING INST CANCER·Filed 2004·Granted Oct 3, 2006·4 cites·8 claims
- 1071US6506875B1Isolated peptides which bind to HLA-C molecules and uses thereofLUDWIG INST CANCER RES·Filed 2000·Granted Jan 14, 2003·1 cites·5 claims
- 1171US6251603B1Method for determining status of a cancerous condition by determining antibodies to NY-ESO-1 in a patient sampleLUDWIG INST CANCER RES·Filed 1999·Granted Jun 26, 2001·34 cites·21 claims
- 1270US7888100B2Isolated nucleic acid molecules which encode immunogenic portions of NY-ESO-1 proteinSLOAN KETTERING INST CANCER·Filed 2006·Granted Feb 15, 2011·0 cites·12 claims
- 1369US6297364B1Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereofLUDWIG INST CANCER RES·Filed 1998·Granted Oct 2, 2001·20 cites·14 claims
- 1467US8071717B2Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereofJAGER DIRK·Filed 2009·Granted Dec 6, 2011·0 cites·2 claims
- 1566US7795379B2Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereofLUDWIG INST CANCER RES·Filed 2005·Granted Sep 14, 2010·1 cites·23 claims
- 1666US7622568B2Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereofLUDWIG INST CANCER RES·Filed 2007·Granted Nov 24, 2009·0 cites·10 claims
- 1764US7795409B2Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereofLUDWIG INST CANCER RES·Filed 2008·Granted Sep 14, 2010·0 cites·6 claims
- 1864US7354992B2Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereofLUDWIG INST CANCER RES·Filed 2003·Granted Apr 8, 2008·0 cites·2 claims
- 1961US7125681B2Methods for detection of disease-associated antibodies in urineLUDWIG INST CANCER RES·Filed 2002·Granted Oct 24, 2006·5 cites·4 claims
- 2059US7132507B2Isolated cancer associated antigens NY-MEL 1 and NY-MEL 3, peptides based thereon, and their usesCORNELL RES FOUNDATION INC·Filed 2002·Granted Nov 7, 2006·0 cites·4 claims
- 2159US6723832B1Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereofLUDWIG INST CANCER RES·Filed 1998·Granted Apr 20, 2004·12 cites·9 claims
- 2255US8142786B2Method for inducing cell lysis with immunogenic portions of NY-ESO-1 proteinKNUTH ALEXANDER·Filed 2011·Granted Mar 27, 2012·0 cites·5 claims
- 2355US6440663B1Renal cancer associated antigens and uses thereforLUDWIG INST CANCER RES·Filed 1998·Granted Aug 27, 2002·19 cites·12 claims
- 2455US2023295566A1Method for producing tumor-infiltrating t-lymphocytes (til) and their use as cellular therapeutics for the treatment of human tumorsZELLWERK GMBH·Filed 2021·Application pending·0 cites
- 2553US7009035B2Isolated peptides which bind to HLA-C molecules and uses thereofSLOAN KETTERING INST CANCER·Filed 2002·Granted Mar 7, 2006·0 cites·5 claims
- 2651US6576756B2Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereofLUDWIG INST CANCER RES·Filed 2001·Granted Jun 10, 2003·0 cites·3 claims
- 2751US2004126398A1Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereofFiled 2000·Application pending·0 cites
- 2849US2003175250A1Isolated peptides which bind to HLA molecules and uses thereofFiled 2003·Application pending·0 cites
- 2947US7632506B2Identification of new NY-ESO-1 epitopes recognized by CD4+ T-cellsLUDWIG INST CANCER RES·Filed 2005·Granted Dec 15, 2009·0 cites·11 claims
- 3043US2021169937A1Method for the treatment of a tumor patient with adoptive t cell immunotherapyNORDWEST POLYBIOCEPT BIOSCIENCE GMBH·Filed 2019·Application pending·0 cites
- 3140US8541202B2Method for inducing cell lysis with immunogenic portions of NY-ESO-1 proteinKNUTH ALEXANDER·Filed 2012·Granted Sep 24, 2013·0 cites·6 claims
- 3239US6830924B1Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereofLUDWIG INST CANCER RES·Filed 1999·Granted Dec 14, 2004·2 cites·20 claims
- 3335US2014093514A1Magea3 binding antibodiesESSLINGER CHRISTOPH·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Elke Jager files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →